Abstract
BackgroundInfiltrating immune cells including monocytes/macrophages have been implicated in the pathogenesis of neovascular age-related macular degeneration (nAMD). The aim of this study was to investigate the cytokine and chemokine expression and secretion profile of peripheral blood mononuclear cells (PBMCs) from nAMD patients and the relationship between the cytokine/chemokine expression profile and clinical phenotype of nAMD, including macular fibrosis, macular atrophy or the responsiveness to anti-VEGF therapy.MethodsOne hundred sixty-one nAMD patients and 43 controls were enrolled in this study. nAMD patients were divided into subgroups based on the presence/absence of (1) macular atrophy, (2) macular fibrosis and (3) responsiveness to anti-VEGF therapy; 25–30 ml of peripheral blood were obtained from all participants and 5 ml were used for serum collection, and the remaining were used for PBMC isolation using density gradient centrifugation. Intracellular cytokine expressions by PBMCs following phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation were examined using flow cytometry. Cytokine productions in lipopolysaccharides (LPS)-or 1% oxygen -treated PBMC were measured using cytometric bead array (CBA) assay. In addition, cytokine and chemokine levels in the serum were also measured by CBA assay.ResultsPBMCs from nAMD patients secreted higher levels of IL-8, CCL2 and VEGF, especially following LPS and 1% oxygen stimulation, than those from controls. 60~80% of IL-8 producing cells were CD11b+CD3− monocytes. The percentage of CD11b+CD3− IL-8+ was significantly increased in nAMD patients compared to controls. PBMCs from nAMD patients without macular fibrosis produced the highest levels of IL-8 and CCL2, whilst PBMCs from nAMD patients with macular atrophy produced highest levels of VEGF. In addition, PBMCs from patients who partially responded to anti-VEGF produced higher levels of IL-8 compared to the cells from complete responders. Interestingly, serum level of CCL2 was not increased in nAMD patients although there was a trend of increased IL-8 in nAMD patients.ConclusionsPBMCs, in particular monocytes, may contribute to CNV development in nAMD through secreting elevated levels of IL-8, CCL2 and VEGF after they are recruited to the macula. Apart from VEGF, IL-8 and CCL2 may be additional targets for nAMD management.
Highlights
Infiltrating immune cells including monocytes/macrophages have been implicated in the pathogenesis of neovascular age-related macular degeneration
Our results show that Peripheral blood mononuclear cell (PBMC) from neovascular age-related macular degeneration (nAMD) patients produce more angiogenic growth factor Vascular endothelial growth factor (VEGF) and chemokines MCP-1 (CCL2) and IL-8 (CXCL8) than those from healthy controls, under inflammatory conditions (e.g. LPS stimulation)
After stimulation with phorbol 12-myristate 13-acetate (PMA)/ionomycin, the percentage of IL-8 producing cells remained higher in nAMD patients compared to controls; the difference was not statistically significant
Summary
Infiltrating immune cells including monocytes/macrophages have been implicated in the pathogenesis of neovascular age-related macular degeneration (nAMD). Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly in the developed world. The therapy can stabilize the disease and even improve vision, not all patients respond to the treatment [1], suggesting that multiple pathways may be involved in the pathogenesis of nAMD. Epidemiological and genetic studies have shown that ageing, environmental factors (e.g. tobacco smoking, diet, hypertension, cardiovascular disease) [2, 3] as well as gene polymorphisms (e.g. complement-related genes (CFH, C3), Toll-like receptors (TLRs) and chemokine receptors (CX3CR1)) [4,5,6,7] increase the risk of AMD. Inflammatory molecules, including complement components, immunoglobulins and C-reactive protein, have been detected in drusen deposits of AMD patients [9]. Inflammatory cytokines (IL-6 and IL-8) have been detected in the aqueous humour of nAMD patients [11]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.